Common hormone could help treat breast cancer
- Details
- Category: Research
Around half of all breast cancer patients could one day benefit from having the cheap and widely-available female hormone progesterone added to their treatment, according to Cancer Research UK funded research published in Nature today. Tumours fuelled by the female hormone oestrogen are treated with drugs like tamoxifen to block oestrogen receptors, which cause cancer cells to grow.
Vitamin C related to reduced risk of cardiovascular disease and early death
- Details
- Category: Research
New research from the University of Copenhagen and Herlev and Gentofte Hospital shows that high vitamin C concentrations in the blood from the intake of fruit and vegetables are associated with a reduced risk of cardiovascular disease and early death. Fruit and vegetables are healthy. We all know that. And now there is yet another good reason for eating lots of it.
Discovery points to a new path toward a universal flu vaccine
- Details
- Category: Research
Flu vaccines can be something of a shot in the dark. Not only must they be given yearly, there's no guarantee the strains against which they protect will be the ones circulating once the season arrives. New research by Rockefeller University scientists and their colleagues suggests it may be possible to harness a previously unknown mechanism within the immune system to create more effective and efficient vaccines against this ever-mutating virus.
Citrus fruit consumption may be associated with increased melanoma risk
- Details
- Category: Research
A new analysis of dietary patterns among more than 100,000 Americans suggests that frequent consumption of citrus - namely whole grapefruit and orange juice - may be associated with an increased risk of melanoma. Melanoma risk was 36% higher in people who consumed citrus fruit or juice at least 1.6 times daily compared to those who consumed them less than twice per week.
First-ever possible treatments for MERS
- Details
- Category: Research
As the South Korean epidemic of Middle East Respiratory Syndrome (MERS) continues unabated, researchers have raced to find treatments for the deadly virus, which has killed more than 400 people since it was first discovered three years ago in Saudi Arabia. Now, scientists at the University of Maryland School of Medicine and Regeneron Pharmaceuticals, Inc., have discovered and validated two therapeutics that show early promise in preventing and treating the disease,
High blood pressure linked to reduced Alzheimer's risk, meds may be reason
- Details
- Category: Research
A new study suggests that people with a genetic predisposition to high blood pressure have a lower risk for Alzheimer's disease. However, authors conclude the connection may have more to do with anti-hypertension medication than high blood pressure itself.
Medical research not addressing patient and clinician priorities
- Details
- Category: Research
Research on treatments for health problems, such as diabetes, stroke and schizophrenia, is not being focused on the treatments considered most important by patients and clinicians, according to a study published in the open access journal Research Involvement and Engagement. The study suggests that current research is instead favoring drug treatments over physical or psychological therapies, or interventions to improve educational approaches or service organization.
More Pharma News ...
- Generic heart disease medications offer promise for Ebola treatment
- Soft core, hard shell - the latest in nanotechnology
- Discovery may lead to targeted melanoma therapies
- Restoring natural immunity against cancers
- Nut consumption associated with reduced risk of some types of cancer
- Behavior matters: Redesigning the clinical trial
- Vitamin D shows promise for treating Crohn's disease in pilot study